AMEND news in Month: February 2026
-
Cryoablation of bone metastases in thyroid and adrenocortical cancers
This study looked at a minimally invasive treatment called cryoablation, which uses extreme cold to destroy cancer that has spread to the bones, in people with thyroid (including MTC) or adrenocortical cancer.
Click here for more information
-
Long-term calcitonin after thyroidectomy for medullary thyroid cancer in MEN2A
This study followed people with MEN2A who had their thyroid removed to understand how often long-term blood tests for calcitonin are really needed.
Click here for more information
-
The prostate is a common site of disease in patients with MEN2B and MTC
A recent study looked at young men with MEN2B (also known as MEN3), which causes medullary thyroid cancer. Doctors found that problems in the prostate were more common than previously thought, even in teenagers.
Click here for more information
-
National Cancer Plan for England Launched
Wednesday 4th February 2026, marked as World Cancer Day, saw the publication of the detailed National Cancer Plan for England by the Department of Health & Social Care
Click here to learn more
-
MEN2B and Family Planning Survey
In collaboration with clinicians at St Bartholomew’s Hospital in London, AMEND would like to learn more about attitudes and experiences of those affected by MEN2B (also known as MEN3) to family planning.
Click to learn more and to participate
-
New MEN1 App Launched
Today, AMEND has launched an app for MEN1 members ensuring that information is always at hand, even if offline. The app replaces the traditional, expensive, and slow-to-receive hardcopy MEN1 Member Pack.
Click here for more information